The World Health Organization (WHO) has reported on phase two of an oral vaccination campaign against cholera taking place from 3-8 July 2019 in the four central provinces of the Democratic Republic of the Congo (DRC), Kasaï, Kasaï Oriental, Lomami and Sankuru. The second dose of vaccine confers lasting immunity against cholera, and is being targeted at 1,235,972 people over one year of age.
The vaccination campaign was launched to contain a serious epidemic, which resulted in 9,154 presumed cases and 458 deaths, with a case-fatality rate of 5% in the Kasaï region between January and December 2018. The DRC reported a cumulative total of 29,304 suspected cholera cases in 2018 and more than 930 deaths, with a case-fatality rate of 3.17%. From 1 January to 9 June 2019, at least 12,247 suspected cases of cholera and 279 deaths, with a case-fatality rate of 2.2%, has been reported.
The campaign is organized by the Ministry of Health with technical, logistic and financial support from the WHO, Gavi the Vaccine Alliance, and the Global Task Force on Cholera Control (GTFCC).
Further information relating to cholera can be found on the TRAVAX (for health professionals) and fitfortravel (for the general public) websites.
Source: WHO Africa, 3 July 2019